GlucoTrack, Inc.
GCTK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $9 | $5 | $2 | $2 |
| G&A Expenses | $0 | $0 | $0 | $2 |
| SG&A Expenses | $5 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $15 | $7 | $4 | $4 |
| Operating Income | -$15 | -$7 | -$4 | -$4 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$8 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$23 | -$7 | -$4 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23 | -$7 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EPS | 60.76 | -38.3 | -28.66 | -26.32 |
| % Growth | 258.6% | -33.6% | -8.9% | – |
| EPS Diluted | 60.76 | -38.3 | -28.66 | -26.32 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$22 | -$7 | -$4 | -$4 |
| % Margin | – | – | – | – |